Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Market watchers are predicting strong results driven by the robust sales of Lilly's blockbuster drugs, particularly its insulin portfolio. However, there are also concerns about potential headwinds fr… Read More